Devices, drugs, and the Food and Drug Administration - Increasing implications for ischemic stroke

被引：14

作者：

Furlan, AJ

Fisher, M

机构：

[1] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA

[2] Cleveland Clin, Dept Neurol, Head Sect Stroke & Neurocrit Care, Cleveland, OH 44106 USA

来源：

STROKE | 2005年 / 36卷 / 02期

关键词：

acute care; stroke; ischemic;

D O I：

10.1161/01.STR.0000153057.07181.94

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：398 / 399

页数：2

共 7 条

[1]

*DEP HLTH HUM SERV, 2000, P NEUR DEV PAN 15 M

[2] Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].

Furlan, A ;

Higashida, R ;

Wechsler, L ;

Gent, M ;

Rowley, H ;

Kase, C ;

Pessin, M ;

Ahuja, A ;

Callahan, F ;

Clark, WM ;

Silver, F ;

Rivera, F .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011

[3]

Levin S, 2004, IN VIVO BUSINESS MED, V18

[4]

SMITH JJ, 2000, DEFINING LEAST BURDE

[5]

*STROK THER AC IND, 2005, IN PRESS STROKE

[6]

TEMPLE R, 1993, FINAL REPORT COMMITT

[7]

2004, GRAY SHEET, V30

← 1 →